Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On February 7, 2023, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published a report entitled, “Technical Assistance Brief: Implementation of...
2022 was an eventful year on the 340B front, packed with updates to consequential litigation, proposed new rules, ongoing uncertainty into the Health Resources and Services...
Baltimore Medical System announced a new pharmacy has opened at its newest community health center in Rosedale.
On January 30, 2023, the United States Court of Appeals for the Third Circuit issued its decision in Sanofi Aventis U.S. LLC v. United States Department of Health and Human Services,...
340B hospitals are seeing Medicare Part B payments restored for certain 340B drugs and biologicals to pre-2018 rates following a rare unanimous SCOTUS decision this summer. Following the SCOTUS decision, here are next steps all impacted 340B hospitals should quickly explore.